The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of timing of recurrence on outcomes in patients with metastatic breast cancer treated with CDK4/6 inhibitors.
 
Sujan Niraula
No Relationships to Disclose
 
Diego Villamarin
No Relationships to Disclose
 
Tae Smith
No Relationships to Disclose
 
Ramandeep Babbra
No Relationships to Disclose
 
Akhil Mahant
No Relationships to Disclose
 
Myla S. Strawderman
No Relationships to Disclose
 
Zeni Kharel
No Relationships to Disclose
 
Christie Tinkham
No Relationships to Disclose
 
Michael Tiongson
No Relationships to Disclose
 
Nikhil Bamarajpet
No Relationships to Disclose
 
Samin Houshyar
No Relationships to Disclose
 
Erica Kim
No Relationships to Disclose
 
Anna Weiss
Consulting or Advisory Role - Merck; Myriad Genetics; Myriad Genetics
Research Funding - Myriad Genetics (Inst)
 
Carla Isadora Falkson
Honoraria - Curio Science
Consulting or Advisory Role - Agendia; bioTheranostics
Speakers' Bureau - OncLive/MJH Life Sciences
Research Funding - Lilly (Inst); Oncolytics (Inst); QuantumLeap Health (Inst)
 
Ruth O'Regan
Honoraria - AstraZeneca/MedImmune; bioTheranostics; Gilead Sciences; Novartis; Pfizer; Puma Biotechnology; Seagen
Consulting or Advisory Role - AstraZeneca/MedImmune; bioTheranostics; Lilly; Novartis; Puma Biotechnology; seagen
Research Funding - Novartis (Inst); Puma Biotechnology (Inst)
 
Huina Zhang
No Relationships to Disclose
 
Ajay Dhakal
Honoraria - AstraZeneca; Gilead Sciences; OncLive/MJH Life Sciences; OncLive/MJH Life Sciences; WebMD/Medscape
Research Funding - Celcuity; Puma Biotechnology